共 50 条
The B Cell Mutator AID Promotes B Lymphoid Blast Crisis and Drug Resistance in Chronic Myeloid Leukemia
被引:123
作者:
Klemm, Lars
[1
,2
,3
]
Duy, Cihangir
[1
,2
,3
]
Iacobucci, Ilaria
[4
]
Kuchen, Stefan
[5
]
von Levetzow, Gregor
[1
,2
,3
]
Feldhahn, Niklas
[3
]
Henke, Nadine
[3
]
Li, Zhiyu
[5
]
Hoffmann, Thomas K.
[3
,8
]
Kim, Yong-mi
[1
,2
]
Hofmann, Wolf-Karsten
[6
]
Jumaa, Hassan
[7
]
Groffen, John
[1
,2
]
Heisterkamp, Nora
[1
,2
]
Martinelli, Giovanni
[4
]
Lieber, Michael R.
[1
]
Casellas, Rafael
[5
]
Mueschen, Markus
[1
,2
,3
]
机构:
[1] Univ So Calif, Leukemia & Lymphoma Program, Kenneth Norris Jr Comprehens Canc Ctr, Los Angeles, CA 90027 USA
[2] Childrens Hosp Los Angeles, Saban Res Inst, Los Angeles, CA 90027 USA
[3] Univ Dusseldorf, D-40225 Dusseldorf, Germany
[4] Univ Bologna, Dept Hematol & Oncol L & A Seragnoli, I-40138 Bologna, Italy
[5] NIAMSD, NIH, Bethesda, MD 20892 USA
[6] Univ Heidelberg Hosp, Dept Hematol Oncol, D-68167 Mannheim, Germany
[7] Max Planck Inst Immunobiol, Freiburg, Germany
[8] Univ Duisburg Essen, Dept Otorhinolaryngol, D-45147 Essen, Germany
来源:
关键词:
INDUCED CYTIDINE DEAMINASE;
ACUTE LYMPHOBLASTIC-LEUKEMIA;
KINASE DOMAIN MUTATIONS;
ACTIVATION-INDUCED DEAMINASE;
CLASS SWITCH RECOMBINATION;
SOMATIC HYPERMUTATION;
TYROSINE KINASE;
DNA DEAMINATION;
CHRONIC PHASE;
C-MYC;
D O I:
10.1016/j.ccr.2009.07.030
中图分类号:
R73 [肿瘤学];
学科分类号:
100214 ;
摘要:
Chronic myeloid leukemia (CIVIL) is induced by BCR-ABL1 and can be effectively treated for many years with Imatinib until leukemia cells acquire drug resistance through BCR-ABL1 mutations and progress into fatal B lymphoid blast crisis (LBC). Despite its clinical significance, the mechanism of progression into LBC is unknown. Here, we show that LBC but not CIVIL cells express the B cell-specific mutator enzyme AID. We demonstrate that AID expression in CIVIL cells promotes overall genetic instability by hypermutation of tumor suppressor and DNA repair genes. Importantly, our data uncover a causative role of AID activity in the acquisition of BCR-ABL1 mutations leading to Imatinib resistance, thus providing a rationale for the rapid development of drug resistance and blast crisis progression.
引用
收藏
页码:232 / 245
页数:14
相关论文
共 50 条